Serious adverse incidents with the usage of low molecular weight heparins in patients with chronic kidney disease
V Farooq, J Hegarty, T Chandrasekar… - American journal of …, 2004 - Elsevier
Background: The aim of the study is to describe serious adverse events in patients with renal
insufficiency administered low molecular weight heparins (LMWHs). Methods: Systematic …
insufficiency administered low molecular weight heparins (LMWHs). Methods: Systematic …
Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis …
G Nowak, E Bucha, I Brauns… - Wiener Klinische …, 1997 - europepmc.org
A 69-year-old female patient with renal failure developed heparin-induced
thrombocytopenia type II (HIT II) two months after starting haemodialysis therapy with …
thrombocytopenia type II (HIT II) two months after starting haemodialysis therapy with …